Get started
Author

Nurulamin Abu Bakar

Observed names: Abu Bakar, Nurulamin, N. Abu Bakar
Observed institutions: Ministry of Health, Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Hospital Selayang, Donders Institute for Brain, Cognition and Behaviour, National University of Malaysia
ORCID: 0000-0001-6818-7973
Observed ORCID: 0000-0001-6818-7973
OpenAlex ID: A5022316643
Oral D-galactose supplementation in PGM1-CDG
2017 · Sunnie Yan-Wai Wong, Therese Gadomski, et al. · Genetics in Medicine · 80
PDF
Clinical glycomics for the diagnosis of congenital disorders of glycosylation
2018 · Nurulamin Abu Bakar, Dirk J. Lefeber, et al. · Journal of Inherited Metabolic Disease · 73
PDF
Integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone mineralization by regulating post-Golgi protein transport and glycosylation
2018 · Angel Ashikov, Nurulamin Abu Bakar, et al. · Human Molecular Genetics · 60
PDF
Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function
2018 · Xiao-Yan Wen, Maja Tarailo-Graovac, et al. · JCI Insight · 59
PDF
PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose
2017 · N.C. Voermans, N. Preisler, et al. · Neuromuscular Disorders · 42
Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots
2020 · Federica Conte, Eva Morava, et al. · Molecular Genetics and Metabolism · 30
PDF
Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency
2018 · Nurulamin Abu Bakar, Nicol C. Voermans, et al. · Translational research · 27
PDF
Synergistic use of glycomics and single‐molecule molecular inversion probes for identification of congenital disorders of glycosylation type‐1
2022 · Nurulamin Abu Bakar, Angel Ashikov, et al. · Journal of Inherited Metabolic Disease · 26
PDF
A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy
2019 · Walinka van Tol, Angel Ashikov, et al. · JIMD Reports · 19
PDF
Advancement in Clinical Glycomics and Glycoproteomics for Congenital Disorders of Glycosylation: Progress and Challenges Ahead
2025 · Nurulamin Abu Bakar, Nurul Izzati Hamzan · Biomedicines · 10
PDF
Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3–4 CKD Using the 2021 CKD-EPI Equations
2026 · Nurulamin Abu Bakar, Nurul Izzati Hamzan, et al. · International Journal of Molecular Sciences · 2
PDF
GAS5 in Colorectal Cancer: A Multifaceted Long Non-Coding RNA in Tumor Suppression, Prognosis and Therapeutic Targeting
2025 · Jiaxian Ong, Sharanya Sritharan, et al. · Advanced Pharmaceutical Bulletin · 1
Multi-Omics Characterization of a Novel SSR4 Variant in Congenital Disorders of Glycosylation
2025 · Nurulamin Abu Bakar, Nurul Izzati Hamzan, et al. · Metabolites · 1
PDF
Multi-Marker Evaluation for GFR Estimation in CKD Using the 2021 CKD-EPI Equations
2025 · Nurulamin Abu Bakar, Nurul Izzati Hamzan, et al. · Preprints.org · 1
PDF
Programme standards medical and health sciences 2025
2025 · Abdullah, Ahmad Fahmi Lim, Appukutty, Mahenderan, et al. · The International Islamic University Malaysia Repository (The International Islamic University Malaysia)
Glycomics by mass spectrometry for the diagnosis of congenital disorders of glycosylation (CDG)
2020 · Nurulamin Abu Bakar · Radboud Repository (Radboud University)
Glycomics as an Innovative Approach for Personalized Medicine
2019 · Stephanie Holst, Nurulamin Abu Bakar, et al. · Chapman & Hall/CRC eBooks
Works count: 17
Citation count: 431
H-index: 10
I10-index: 10
Year
Topic
Type